1. Home
  2. ENTA vs ATLO Comparison

ENTA vs ATLO Comparison

Compare ENTA & ATLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTA
  • ATLO
  • Stock Information
  • Founded
  • ENTA 1995
  • ATLO 1903
  • Country
  • ENTA United States
  • ATLO United States
  • Employees
  • ENTA N/A
  • ATLO N/A
  • Industry
  • ENTA Biotechnology: Pharmaceutical Preparations
  • ATLO Major Banks
  • Sector
  • ENTA Health Care
  • ATLO Finance
  • Exchange
  • ENTA Nasdaq
  • ATLO Nasdaq
  • Market Cap
  • ENTA 164.6M
  • ATLO 177.0M
  • IPO Year
  • ENTA 2013
  • ATLO N/A
  • Fundamental
  • Price
  • ENTA $7.84
  • ATLO $20.65
  • Analyst Decision
  • ENTA Strong Buy
  • ATLO
  • Analyst Count
  • ENTA 5
  • ATLO 0
  • Target Price
  • ENTA $20.20
  • ATLO N/A
  • AVG Volume (30 Days)
  • ENTA 164.6K
  • ATLO 14.3K
  • Earning Date
  • ENTA 08-11-2025
  • ATLO 11-07-2025
  • Dividend Yield
  • ENTA N/A
  • ATLO 3.92%
  • EPS Growth
  • ENTA N/A
  • ATLO 43.95
  • EPS
  • ENTA N/A
  • ATLO 1.53
  • Revenue
  • ENTA $64,806,000.00
  • ATLO $57,731,000.00
  • Revenue This Year
  • ENTA N/A
  • ATLO N/A
  • Revenue Next Year
  • ENTA $1.65
  • ATLO N/A
  • P/E Ratio
  • ENTA N/A
  • ATLO $13.36
  • Revenue Growth
  • ENTA N/A
  • ATLO 12.59
  • 52 Week Low
  • ENTA $4.09
  • ATLO $15.69
  • 52 Week High
  • ENTA $13.37
  • ATLO $20.77
  • Technical
  • Relative Strength Index (RSI)
  • ENTA 45.61
  • ATLO 66.69
  • Support Level
  • ENTA $7.28
  • ATLO $20.26
  • Resistance Level
  • ENTA $8.86
  • ATLO $20.72
  • Average True Range (ATR)
  • ENTA 0.53
  • ATLO 0.35
  • MACD
  • ENTA -0.18
  • ATLO -0.00
  • Stochastic Oscillator
  • ENTA 29.63
  • ATLO 89.74

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.

Share on Social Networks: